Close
ACHEMA MIDDLE EAST 2026

DelMar Pharmaceuticals Receives IRB Approval for Pivotal Phase 3 Clinical Trial of VAL-083

DelMar Pharmaceuticals  , a biopharmaceutical company focused on the development of new cancer therapies, announced it has received Institutional Review Board (IRB) approval to...

FierceBiotech’sDrug Development Forum Attracts Executive-Level Biopharma Professionals for Second Annual Conference in Boston This September

Attendees of FierceBiotech’s 2ndAnnual Drug Development Forum will obtain essential funding strategies and more productive R&D through executive-level networking opportunities. Convening at the Renaissance...

FDA chooses Zepsyre from PharmaMar to explore potential development for pediatric cancers

The Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (ODAC) of the FDA, has invited PharmaMar to participate in this ODAC, giving a presentation to...

Evoke Pharma Enters Agreement with Rho to Submit NDA for Gimoti

Evoke Pharma Inc , a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases announced that it has entered into an agreement with...

Nutra Pharma and University of Maryland Bioprocess Scale-Up Facility for Phase II Studies

Nutra Pharma Corporation , a biotechnology company marketing Nyloxin® and Pet Pain-Away™ in the over-the-counter (OTC) pain management market, and which is also developing...

GE Healthcare’s FlexFactory to power Dr. Reddy’s biosimilar expansion plans

GE Healthcare announced that Dr. Reddy’s Laboratories Limited will install India’s first-ever FlexFactory, a single-use manufacturing platform to expand the biologics production capacity at...

Recro Pharma Presents Phase III Bunionectomy Clinical Data For IV Meloxicam

Recro Pharma, Inc. , a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute care settings announced the presentation of...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...